These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28299430)

  • 21. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review.
    Chiappini E; Bonsignori F; Accetta G; Boddi V; Galli L; Biggeri A; De Martino M
    Int J Immunopathol Pharmacol; 2012; 25(2):335-43. PubMed ID: 22697065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of interferon-γ and IP-10 for the diagnosis of tuberculosis.
    Holm LL; Rose MV; Kimaro G; Bygbjerg IC; Mfinanga SG; Ravn P; Ruhwald M
    Pediatrics; 2014 Dec; 134(6):e1568-75. PubMed ID: 25422019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine/chemokine secretion for detecting tuberculosis in quantiferon supernatants from HIV
    Jeljeli M; Guérin-El Khourouj V; Pommelet V; Hormi M; Gressens P; Faye A; Sterkers G
    J Infect; 2017 Jul; 75(1):77-80. PubMed ID: 28478123
    [No Abstract]   [Full Text] [Related]  

  • 25. Development and evaluation of a new interferon-gamma release assay for the diagnosis of tuberculosis infection in HIV-infected individuals in China.
    Yu L; Mo P; Wei Z; Fu R; Yang M; Ji B; Wang J; Li S; Strong AJ; Touzjian N; Kushner N; Gui XE; Lu Y; Zhao Z
    Infect Dis (Lond); 2015 Apr; 47(4):237-43. PubMed ID: 25712792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer) using QuantiFERON
    Bernitz N; Clarke C; Roos EO; Goosen WJ; Cooper D; van Helden PD; Parsons SDC; Miller MA
    Vet Immunol Immunopathol; 2018 Feb; 196():48-52. PubMed ID: 29695324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
    Mazurek GH; Jereb J; Vernon A; LoBue P; Goldberg S; Castro K; ;
    MMWR Recomm Rep; 2010 Jun; 59(RR-5):1-25. PubMed ID: 20577159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
    Suzukawa M; Akashi S; Nagai H; Nagase H; Nakamura H; Matsui H; Hebisawa A; Ohta K
    PLoS One; 2016; 11(4):e0152483. PubMed ID: 27035669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.
    Zellweger JP; Sotgiu G; Block M; Dore S; Altet N; Blunschi R; Bogyi M; Bothamley G; Bothe C; Codecasa L; Costa P; Dominguez J; Duarte R; Fløe A; Fresard I; García-García JM; Goletti D; Halm P; Hellwig D; Henninger E; Heykes-Uden H; Horn L; Kruczak K; Latorre I; Pache G; Rath H; Ringshausen FC; Ruiz AS; Solovic I; Souza-Galvão ML; Widmer U; Witte P; Lange C;
    Am J Respir Crit Care Med; 2015 May; 191(10):1176-84. PubMed ID: 25763458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH; Weis SE; Moonan PK; Daley CL; Bernardo J; Lardizabal AA; Reves RR; Toney SR; Daniels LJ; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):837-45. PubMed ID: 17806047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response.
    Sauzullo I; Mengoni F; Ermocida A; Massetti AP; D'Agostino C; Russo G; Salotti A; Falciano M; Vullo V; Mastroianni CM
    New Microbiol; 2014 Apr; 37(2):153-61. PubMed ID: 24858642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.
    Vanini V; Petruccioli E; Gioia C; Cuzzi G; Orchi N; Rianda A; Alba L; Giancola ML; Conte A; Schininà V; Rizzi EB; Girardi E; Goletti D
    J Infect; 2012 Jul; 65(1):49-59. PubMed ID: 22465752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway.
    Pullar ND; Steinum H; Tonby K; Heggelund L; Leiva RA; Ofstad R; Bruun JN; Dyrhol-Riise AM
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):180-7. PubMed ID: 24429310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study.
    Gourgouillon N; de Lauzanne A; Cottart CH; Curis E; Debord C; Guérin-El Khourouj V; Pédron B; Faye A; Sterkers G
    Pediatr Res; 2012 Oct; 72(4):370-4. PubMed ID: 22797138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection.
    Petrucci R; Abu Amer N; Gurgel RQ; Sherchand JB; Doria L; Lama C; Ravn P; Ruhwald M; Yassin M; Harper G; Cuevas LE
    Pediatr Infect Dis J; 2008 Dec; 27(12):1073-7. PubMed ID: 18946366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study.
    Elliott AM; Hurst TJ; Balyeku MN; Quigley MA; Kaleebu P; French N; Biryahwaho B; Whitworth JA; Dockrell HM; Hayes RJ
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):239-47. PubMed ID: 10094326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.
    Ruhwald M; Petersen J; Kofoed K; Nakaoka H; Cuevas LE; Lawson L; Squire SB; Eugen-Olsen J; Ravn P
    PLoS One; 2008 Aug; 3(8):e2858. PubMed ID: 18682747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden.
    Mthiyane T; Rustomjee R; Pym A; Connolly C; Onyebujoh P; Theron G; Dheda K
    Int J Infect Dis; 2015 Jul; 36():46-53. PubMed ID: 26003404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.